1. Two-year change in cognitive function is associated with changes in vascular function in a diverse cohort of middle-aged adults at-risk for Alzheimer's disease
- Author
-
Brittany Butts, William Hu, Arshed Quyyumi, Monica Parker, Sonum Tharwani, Harry Huang, Danielle Verble, and Whitney Wharton
- Subjects
Specialties of internal medicine ,RC581-951 ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Introduction: The rate of Alzheimer's disease (AD) for Black Americans (BAs) is 64% higher than for non-Hispanic White Americans (NHWs). Vascular dysfunction may directly contribute to pathologies related to AD and cognitive decline. The purpose of this study is to examine relationships between vascular function and cognition over two years in a diverse cohort of middle-aged adults at-risk for AD. Methods: Cognitively unimpaired, middle-aged (45-65 years) adults with a parental history of AD were enrolled. Vascular function measures (flow-mediated dilation [FMD], EndoPat, pulse wave velocity [PWV], blood pressure [BP]) CSF markers of vascular function (ICAM-1, VCAM-1), and the Benson Complex Figure Test were collected at baseline and year 2. Linear regression analyses accounting for related covariates (age, gender, race, history of hypertension, and APOE ε4) were performed. Results: Participants (N=80) were mostly female (69%), well educated (81% ≥college), 48% ApoEε4 positive, and 34% B/AA. A higher proportion of B/AA had hypertension as compared to NHWs (57% vs 34%, p=.041). Central systolic BP, central mean arterial pressure, and EndoPat augmentation index were higher among BAs at baseline, while FMD was significantly lower at year 2. Increased CSF VCAM-1 was associated with lower FMD over 2 years. Changes in delayed Benson scores were significantly higher among NHWs (median change score 2, 95% CI 0.81-2.6) as compared to BAs (median change score 0, 95% CI -2.0-0.4) with a large effect size (Cohen's d=.823, p
- Published
- 2024
- Full Text
- View/download PDF